Therapy resistance by splicing: can the androgen receptor teach us about BRAF?
jfqi@burnham.org
Jianfei
J
Qi
D019943:Amino Acid Substitution / Q000235:genetics / Q000502:physiology; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D004843:Epistasis, Genetic / Q000502:physiology; D006801:Humans; D008495:Medical Oncology / Q000193:education / Q000379:methods / Q000639:trends; D058990:Molecular Targeted Therapy / Q000379:methods / Q000639:trends; D020125:Mutation, Missense / Q000502:physiology; D055503:Protein Multimerization / Q000235:genetics; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics* / Q000502:physiology; D012326:RNA Splicing / Q000235:genetics / Q000502:physiology*; D011944:Receptors, Androgen / Q000235:genetics* / Q000502:physiology*; D013663:Teaching
C410798:AR protein, human; D011944:Receptors, Androgen; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf